Skip to main content
. 2021 Oct 15;13(10):1229–1243. doi: 10.4251/wjgo.v13.i10.1229

Table 2.

Small molecules able to inhibit autophagic activity

Agents
Mechanism of action
3-Methyladenine (3-MA) Inhibitor of class III PI3K
LY294002 PI3K inhibitor
Wortmannin PI3K inhibitor
SB202190 Cross-inhibition of the PI3K/mTOR and MAPKs pathway
MHY1485 Activator of mTOR
Azithromycin Inhibitor of v-ATPase, inhibition of lysosomal acidification
Bafilomycin A1 Inhibitor of v-ATPase, inhibition of lysosomal acidification
Concanamycin A Inhibitor of v-ATPase, inhibition of lysosomal acidification
Chloroquine (CQ) Autophagosome-lysosome fusion
Hydroxy-chloroquine (HCQ) Autophagosome-lysosome fusion
Clomipramine Alter acidification of lysosomes
Verteporfin Alter acidification of lysosomes
Paclitaxel Microtubule stabilizer- inhibit phosphorylation of VPS34 at T159
Spain-1 Inhibits the activity of ubiquitin-specific peptidases, USP10 and USP13
Monensin Inhibit autophagosome-lysosome fusion

PI3K: Phosphatidylinositol 3-kinases; mTORC1: Mammalian target of rapamycin complex 1; AMPK: 5’ AMP-activated protein kinase;VPS: Vacuolar protein sorting; ATG: Autophagy-related proteins; USP: Ubiquitin-specific protease.